Notable Labs
-
Startups, Artificial Intelligence, BioPharma
Personalized cancer treatment startup Notable Labs nabs $40M Series B
Notable CEO Matthew De Silva said the company has been able to successfully replicate its automated system, allowing for the export of the company’s technology and growth of its commercial use cases.
-
Stanford, Notable Labs and Tempus collaborate on personalized medicine research for blood cancer
The feasibility study was meant to see whether personalized cancer genetic sequencing and drug sensitivity recommendations could be done in a “clinically reasonable amount of time.”
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Health IT, Artificial Intelligence
Sutter Health partners with voice-enabled AI startup to reduce clinician administrative burden
Suki’s pilot program with Sutter will introduce the Redwood City-based company’s technology across three specialties: primary care, dermatology and orthopedics.
-
Silicon Valley startup launches first drug development program with novel nonprofit partnership
The company’s initial program, known as ND-1000, is a combination of an existing generic cancer medication with a natural product that is meant to boost the effectiveness of CAR T-Cell therapy.